We are live on ! Find out more
ANAB icon

AnaptysBio
ANAB

71 hedge funds and large institutions have $620M invested in AnaptysBio in 2017 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 31 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

317% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 6

210% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 10

89% more capital invested

Capital invested by funds: $328M → $620M (+$292M)

37% more funds holding

Funds holding: 52 → 71 (+19)

19.57% more ownership

Funds ownership: 67.61% → 87.17% (+20%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
71
Holders Change
+19
Holders Change %
+36.54%
% of All Funds
1.77%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
25
Increased
31
Reduced
10
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$59.1M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$18.5M
3
Citadel Advisors
Citadel Advisors
Florida
+$15.7M
4
BlackRock
BlackRock
New York
+$10.3M
5
Millennium Management
Millennium Management
New York
+$7.49M

Top Sellers

1
NHAS
Novo Holdings A/S
Denmark
-$49.7M
2
BI
BVF Inc
California
-$7.55M
3
MWNA
Marshall Wace North America
New York
-$4.27M
4
ACP
Acuta Capital Partners
California
-$3.96M
5
AG
Artal Group
Luxembourg
-$2.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
FM
1
Frazier Management
Washington
$129M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$76.6M +$59.1M +2,192,030 New
BI
3
BVF Inc
California
$48.2M -$7.55M -280,066 -17%
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$42.6M +$18.5M +687,310 +129%
NHAS
5
Novo Holdings A/S
Denmark
$41.6M -$49.7M -1,842,900 -61%
CAM
6
Cormorant Asset Management
Massachusetts
$35M +$5.41M +200,531 +25%
PA
7
Perceptive Advisors
New York
$34.3M +$809K +30,000 +3%
DM
8
Deerfield Management
New York
$28.8M +$7.32M +271,479 +49%
BlackRock
9
BlackRock
New York
$23.9M +$10.3M +380,575 +126%
Citadel Advisors
10
Citadel Advisors
Florida
$20.4M +$15.7M +583,849 New
Vanguard Group
11
Vanguard Group
Pennsylvania
$14.9M +$5.93M +219,955 +107%
Millennium Management
12
Millennium Management
New York
$11.4M +$7.49M +277,500 +573%
Franklin Resources
13
Franklin Resources
California
$9.76M – – –
FCM
14
Farallon Capital Management
California
$8.6M +$6.64M +246,000 New
JP Morgan Chase
15
JP Morgan Chase
New York
$6.36M +$3.35M +124,219 +210%
VMI
16
VHCP Management II
New York
$5.86M +$4.52M +167,550 New
Federated Hermes
17
Federated Hermes
Pennsylvania
$5.84M -$890K -33,000 -17%
AG
18
Artal Group
Luxembourg
$5.24M -$2.7M -100,000 -40%
RSCM
19
Rock Springs Capital Management
Maryland
$5.24M +$4.05M +150,000 New
State Street
20
State Street
Massachusetts
$4.47M +$1.43M +53,086 +71%
Northern Trust
21
Northern Trust
Illinois
$4.41M +$1.79M +66,264 +110%
Citigroup
22
Citigroup
New York
$4.29M +$3.26M +120,787 +6,522%
SIM
23
Spark Investment Management
New York
$4.24M +$1.28M +47,300 +64%
BBA
24
Baker Bros. Advisors
New York
$3.89M -$157K -5,825 -5%
Goldman Sachs
25
Goldman Sachs
New York
$3.76M +$2.59M +95,994 +830%
1
2 3 4

ANAB Hedge Fund Activity: Q3 2017 in Review

71 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q3 2017, worth a combined $620M — up 89% from $328M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ANAB positions and 6 closed out — a net gain of 19 holders — while 31 added to existing stakes and 10 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $59.1M. The largest seller was Novo Holdings A/S, cutting an estimated $49.7M.

  • 71 institutional investors held AnaptysBio (ANAB) as of Q3 2017, up from 52 in Q2 2017.
  • Funds reported $620M of AnaptysBio stock for Q3 2017, up 89% quarter-over-quarter.
  • 25 funds opened new AnaptysBio positions in Q3 2017 and 6 closed out, a net change of +19 holders.
  • The largest AnaptysBio buyer in Q3 2017 was Fidelity Investments, an estimated $59.1M added.
  • The largest AnaptysBio seller in Q3 2017 was Novo Holdings A/S, an estimated $49.7M sold.

Based on aggregated 13F filings for Q3 2017.